Top-Rated StocksTop-RatedNASDAQ:IRTC iRhythm Technologies (IRTC) Stock Price, News & Analysis $109.08 +1.41 (+1.30%) As of 02:15 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About iRhythm Technologies Stock (NASDAQ:IRTC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get iRhythm Technologies alerts:Sign Up Key Stats Today's Range$106.39▼$109.6250-Day Range$101.79▼$126.4852-Week Range$100.85▼$212.00Volume126,195 shsAverage Volume601,574 shsMarket Capitalization$3.58 billionP/E RatioN/ADividend YieldN/APrice Target$184.71Consensus RatingBuy Company Overview iRhythm Technologies, Inc. is a medical technology company that develops and commercializes wearable cardiac monitoring devices and associated data analytics services. Founded in 2006 and headquartered in San Francisco, California, the company’s flagship product is the Zio® patch, a discreet, single-use, continuous ECG recorder designed to monitor heart rhythms for up to 14 days. iRhythm’s digital diagnostics platform combines biosensor technology with proprietary algorithms to detect arrhythmias and streamline data interpretation for physicians. The Zio service is prescribed by cardiologists and other healthcare providers to aid in the diagnosis of atrial fibrillation, bradycardia, tachycardia and other rhythm disorders. After wearing the water-resistant patch, patients mail it back to iRhythm’s central lab, where recorded data are analyzed using the company’s AI-powered architecture. A comprehensive report, including annotated ECG strips and rhythm diagnosis, is delivered directly to the prescribing clinician, helping to guide treatment decisions. iRhythm primarily serves the United States market through partnerships with hospitals, clinics and diagnostic laboratories, and the company has been expanding its global footprint through strategic collaborations and regulatory approvals in select international markets. Leadership is headed by President and Chief Executive Officer Kevin King, who has overseen product innovation and process enhancements to support scalable growth. iRhythm continues to invest in research and development to extend its diagnostic platform into emerging areas of cardiovascular care and digital health.AI Generated. May Contain Errors. Read More iRhythm Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks81st Percentile Overall ScoreIRTC MarketRank™: iRhythm Technologies scored higher than 81% of companies evaluated by MarketBeat, and ranked 99th out of 835 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingBuy Consensus RatingiRhythm Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 strong buy ratings, 12 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialiRhythm Technologies has a consensus price target of $184.71, representing about 68.9% upside from its current price of $109.38.Amount of Analyst CoverageiRhythm Technologies has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about iRhythm Technologies' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth907.69% Earnings GrowthEarnings for iRhythm Technologies are expected to grow by 907.69% in the coming year, from $0.13 to $1.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -127.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -127.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 23.08. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about iRhythm Technologies' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.95% of the float of iRhythm Technologies has been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 4.59.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 10.44%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. News and Social Media2.8 / 5News Sentiment0.51 News SentimentiRhythm Technologies has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 13 news articles for iRhythm Technologies this week, compared to 5 articles on an average week.Search InterestOnly 2 people have searched for IRTC on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.MarketBeat Follows1 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership2.2 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $56,892.00 in company stock, which represents 0.0016% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $56,892.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders0.98% of the stock of iRhythm Technologies is held by insiders.Percentage Held by InstitutionsiRhythm Technologies has minimal institutional ownership at this time.Read more about iRhythm Technologies' insider trading history. Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IRTC Stock News HeadlinesiRhythm Technologies (NASDAQ:IRTC) Stock Price Down 5.3% on Analyst DowngradeJuly 19, 2026 | americanbankingnews.comTruist Financial Lowers iRhythm Technologies (NASDAQ:IRTC) Price Target to $160.00July 18, 2026 | americanbankingnews.comWill you miss the REAL SpaceX opportunity?When SpaceX went public, retail traders rushed to buy the stock itself. Millionaire trader Tim Bohen says that misses the point entirely. History shows the real opportunities from a company of SpaceX's size emerge in the aftermath, not the IPO frenzy. Bohen called Tesla in 2020 at just $37 a share, and now says he's more bullish than ever with Elon Musk becoming the world's first trillionaire.July 24 at 1:00 AM | StocksToTrade (Ad)iRhythm Technologies (NASDAQ:IRTC) Given Average Recommendation of "Moderate Buy" by BrokeragesJuly 18, 2026 | americanbankingnews.comiRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026July 16, 2026 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA) and Irhythm Technologies (IRTC)July 11, 2026 | theglobeandmail.comQ1 Earnings Roundup: iRhythm (NASDAQ:IRTC) And The Rest Of The Patient Monitoring SegmentJuly 3, 2026 | finance.yahoo.comDid iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?July 3, 2026 | prnewswire.comSee More Headlines IRTC Stock Analysis - Frequently Asked Questions How have IRTC shares performed this year? iRhythm Technologies' stock was trading at $177.44 on January 1st, 2026. Since then, IRTC shares have decreased by 38.4% and is now trading at $109.38. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies (NASDAQ:IRTC) announced its quarterly earnings results on Thursday, April, 30th. The company reported ($0.35) EPS for the quarter, topping analysts' consensus estimates of ($0.56) by $0.21. iRhythm Technologies's revenue was up 25.6% compared to the same quarter last year. Read the conference call transcript. When did iRhythm Technologies IPO? iRhythm Technologies (IRTC) raised $88 million in an initial public offering (IPO) on Thursday, October 20th 2016. The company issued 6,294,118 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Who are iRhythm Technologies' major shareholders? iRhythm Technologies' top institutional shareholders include Assenagon Asset Management S.A. (0.07%), Handelsbanken Fonder AB (0.04%), Hennion & Walsh Asset Management Inc. (0.01%) and Harbor Investment Advisory LLC. Insiders that own company stock include Quentin S Blackford, Mark J Day, Patrick Michael Murphy, Chad Patterson, Minang Turakhia, Sumi Shrishrimal, Daniel G Wilson, Mervin Smith, Abhijit Y Talwalkar, Brice Bobzien, Marc Wade Rosenbaum and Marc W Rosenbaum. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that iRhythm Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and ServiceNow (NOW). Company Calendar Last Earnings4/30/2026Today7/24/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (4m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 IRTC's financial health is in the Red zone, according to TradeSmith. IRTC has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryMedical Equipment Current SymbolNASDAQ:IRTC CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees2,400Year Founded2006Price Target and Rating Average Price Target for iRhythm Technologies$184.71 High Price Target$255.00 Low Price Target$147.00 Potential Upside/Downside+69.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage17 Analysts Profitability EPS (Trailing Twelve Months)($0.86) Trailing P/E RatioN/A Forward P/E Ratio839.04 P/E GrowthN/ANet Income-$44.55 million Net Margins-3.53% Pretax Margin-3.43% Return on Equity-10.26% Return on Assets-1.39% Debt Debt-to-Equity Ratio4.03 Current Ratio5.17 Quick Ratio4.98 Sales & Book Value Annual Sales$747.14 million Price / Sales4.80 Cash FlowN/A Price / Cash FlowN/A Book Value$4.74 per share Price / Book23.01Miscellaneous Outstanding Shares32,860,000Free Float32,540,000Market Cap$3.58 billion OptionableOptionable Beta1.27 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:IRTC) was last updated on 7/24/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredElon's next move will be bigger than the IPO – and it could happen any day nowHedge fund legend Larry Benedict - who delivered a 279% return on cash in 2025 and went on a 20-year winning s...Brownstone Research | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredNNVC Gets FDA Boost and Eye Watering Analyst TargetsNanoViricides (NYSE: NNVC) just secured FDA Orphan Drug and Rare Pediatric Disease Designations for its measle...Equiscreen | SponsoredWill you miss the REAL SpaceX opportunity?When SpaceX went public, retail traders rushed to buy the stock itself. Millionaire trader Tim Bohen says that...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
